Cortellis for Competitive Intelligence

Discover the undiscovered with Cortellis for Competitive Intelligence

At a glance

Highlights

  • Intuitive web-based interface
  • Expert analytics & visualizations
  • Export & reporting tools

Intended for

  • Business Development Professional
  • Competitive Intelligence Professional
  • Research & Development Professionals

Description

Thomson Reuters Cortellis™ for Competitive Intelligence combines the same premier information used by the world's leading pharmaceutical companies from products such as Thomson Reuters Pharma™ and Thomson Reuters PartneringTM (formerly IDDB). Featuring daily updates and timely drug pipeline information expertly uncovered and integrated from a variety of sources and global meetings coverage, you'll always be on top of the latest developments. Whether you're putting together a pipeline analysis, or developing a comprehensive competitive intelligence study, Cortellis for Competitive Intelligence can get you to the critical information you need, faster.

To find out more, visit us on the Cortellis website.

Already a customer?

Features

  • An easy and intuitive web-based interface – find the exact data you want, whenever you want
  • Speed decision making – with easy-to-use analytics and visualizations to quickly interrogate data
  • Share and present your findings – with agile export and reporting tools
  • Drug profiles providing a history of the drug: companies involved in drug discovery and development, patent protection, chemical structure, target / MoA, indications in development.
  • Details on discovery-stage, and pre-clinical data & clinical development, including ongoing and completed clinical trials
  • Company profiles: descriptions of your competitors' areas of focus, financial state, drug pipelines, and listings of significant partnerships and drug licensing deals
  • Deals: including financial terms, milestones, timelines and relevant drugs and patents associated with each deal
  • Patents: expirations, infringements, and exclusivity
  • Forecasts: on similar drugs provide insight and a starting point for forecasting sales potential

Benefits

  • Identify market gaps early
  • Look for potential partners
  • Assess comparable deals
  • Discover targets with active patenting activity
  • Research competitor pipelines
  • Review a company’s strategic portfolio

Display Settings:

The application is best viewed at a monitor resolution of 1024 by 768 pixels or higher, and at 256 colors or more (High Color or True Color recommended).

Browser Requirements:

Microsoft® Internet Explorer version 6.0 or higher, or alternatively Mozilla Firefox® 3.6 or higher, within a Windows XP operating environment. Internet Options: Exported results/reports are downloaded into a separate browser window. You must therefore ensure you temporarily disable/turn off any pop-up blockers on your computer, since the content will not export correctly when a pop-up blocker is active.

Javascript:

The application uses JavaScript for defining menus and navigation, opening new windows and for the processing of requests. You must therefore enable the JavaScript option within your web browser to use the application successfully.

Cookies:

In order to utilize all of the features available in the application, we recommend updating your Internet settings to enable or allow cookies for this website.

Adobe Reader:

The application provides some exports in PDF format, to enable easy viewing and printing. You must therefore ensure that Adobe Reader is installed on your machine to export successfully. Adobe Reader is available for download free of charge, from the Adobe website.

* Approval Packages
* Disease Briefings
* US Trial Protocols

  • MT @Reuters_Health: Eli Lilly studying deaths of two patients on long-acting Zyprexa reut.rs/19fShl7 #FDA

    7h 0 0

  • Transition receives $7 million for returning type 2 diabetes drug TT-401 back to Eli Lilly in $262 million agreement

    9h 0 0

  • Mar from the Cortellis editorial team will be attending in Chicago the American Diabetes Association meeting later this week #2013ADA

    10h 0 1

  • Visit Twitter

Download Fact Sheet

Fact Sheets